openPR Logo
Press release

Top Market Shifts Transforming the Neurocutaneous Disorder Market Landscape: Key Insights

10-08-2025 11:06 AM CET | Health & Medicine

Press release from: The Business Research Company

Neurocutaneous Disorder Market

Neurocutaneous Disorder Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Neurocutaneous Disorder Market Through 2025?
In the recent past, the market size for neurocutaneous disorders has witnessed remarkable growth. It's projected to expand from $2.05 billion in 2024 to $2.22 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.5%. Factors contributing to the growth during the historic period include, increased incidence of genetic disorders, heightened sensitivity towards rare neurological conditions, wider adoption of diagnostic imaging, increased patient visits to specialty clinics, and an intensified clinical focus on pediatric neurology.

What's the Projected Size of the Global Neurocutaneous Disorder Market by 2029?
Anticipations are high for robust expansion in the neurocutaneous disorder market over the coming years. Projections suggest that by 2029 it will reach $3.04 billion, boasting a compound annual growth rate (CAGR) of 8.2%. This predicted surge for the forecast period is due to an increasing demand for specific drug treatments, growing numbers of clinical trials for uncommon diseases, expanding collaborations between research institutions, higher usage of genetic testing services and a rise in healthcare spending on neurological care. Key trends to watch in the forecast period include advancements in genomic sequencing technology, groundbreaking innovations in gene therapy, an upswing in R&D investment for novel treatments, progress in digital health monitoring devices, and advancements in diagnostics based on biomarkers.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neurocutaneous-disorder-global-market-report

Top Growth Drivers in the Neurocutaneous Disorder Industry: What's Accelerating the Market?
Rising incidences of genetic disorders are anticipated to stimulate the expansion of the neurocutaneous disorder market in the future. These disorders are the result of DNA abnormalities in a person, which can be hereditary or develop naturally. Neurocutaneous conditions, such as tuberous sclerosis complex and neurofibromatosis, originate from distinct genetic mutations impacting both the nervous and skin systems, resulting in neurological signs along with specific skin anomalies. Developments in genetic testing and heightened awareness have facilitated early detection, leading to an increased reported prevalence. For example, the Centers for Disease Control and Prevention (CDC), a government agency based in the US, stated in November 2024 that about 1 in every 33 newborns in the US has a birth defect, many related to genetic factors. Consequently, the escalating occurrences of genetic disorders are propelling the growth of the neurocutaneous disorder market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28278&type=smp

What Trends Will Shape the Neurocutaneous Disorder Market Through 2029 and Beyond?
Prominent businesses in the neurocutaneous disorder sector are concentrating their efforts to receive regulatory sanctions in order to broaden their treatment range, improve patient results, and take advantage of the increasing demand for cutting-edge therapies. Regulatory approvals mean formal licenses granted by government bodies that give firms the legal rights to market, sell, or evaluate a drug or treatment after ensuring its safety and efficacy. For example, AstraZeneca plc, a pharmaceutical and biotechnology firm from the UK, was given approval by the Food and Drug Administration (FDA) in September 2025 for the drug selumetinib (commercial name Koselugo). This is intended for treating pediatric patients who are 1 year or older with neurofibromatosis type 1 (NF1) and have symptomatic, unmanagable plexiform neurofibromas (PNs). This expands previously approved usage, including children 2 years and older. Selumetinib, a MEK suppressant, functions by inhibiting the MAPK pathway that fuels tumor growth in NF1. Patients take selumetinib orally twice daily until the progression of the disease or intolerable side effects arise, common reactions include gastrointestinal, skin, cardiac, and eye-related toxicity. This approval provides a significant treatment alternative for young children grappling with these challenging and often altering tumors that are frequently hard to address surgically.

What Are the Main Segments in the Neurocutaneous Disorder Market?
The neurocutaneous disorder market covered in this report is segmented as

1) By Type Of Neurocutaneous Disorder: Neurofibromatosis, Tuberous Sclerosis Complex, Sturge-Weber Syndrome, Angiomatosis, Hypomelanosis Of Ito
2) By Treatment Type: Pharmacological Treatment, Surgical Intervention, Laser Therapy, Physical Therapy, Psychosocial Support
3) By Age Group: Pediatric Patients (0-18 Years), Adult Patients (19-65 Years), Geriatric Patients (65 Years And Above)
4) By Severity Of Condition: Mild Cases, Moderate Cases, Severe Cases, Critical Cases
5) By End User: Hospitals, Specialist Clinics, Homecare Settings, Research Organizations, Pharmaceutical Companies

Subsegments:
1) By Neurofibromatosis: Peripheral Neurofibromatosis, Central Neurofibromatosis, Plexiform Neurofibromatosis
2) By Tuberous Sclerosis Complex: Classic Tuberous Sclerosis, Infantile-Onset Tuberous Sclerosis, Adult-Onset Tuberous Sclerosis
3) By Sturge-Weber Syndrome: Facial Sturge-Weber Syndrome, Cerebral Sturge-Weber Syndrome, Ophthalmic Sturge-Weber Syndrome
4) By Angiomatosis: Generalized Angiomatosis, Localized Angiomatosis, Mixed Angiomatosis
5) By Hypomelanosis Of Ito: Linear Hypomelanosis, Segmental Hypomelanosis, Whorled Hypomelanosis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28278&type=smp

Which Top Companies are Driving Growth in the Neurocutaneous Disorder Market?
Major companies operating in the neurocutaneous disorder market are Merck KGaA, AbbVie Inc., Sanofi S.A., Novartis AG, Recursion Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Fosun Pharmaceutical Group Co. Ltd., ioMarin Pharmaceutical Inc., Simcere Pharmaceutical Group, Marinus Pharmaceuticals Inc., Inhibikase Therapeutics Inc., Healx Limited, NF2 Therapeutics Inc., NFlection Therapeutics Inc., Ovid Therapeutics Inc., CureAge Therapeutics, GW Pharmaceuticals plc.

Which Regions Will Dominate the Neurocutaneous Disorder Market Through 2029?
North America was the largest region in the neurocutaneous disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurocutaneous disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28278

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Market Shifts Transforming the Neurocutaneous Disorder Market Landscape: Key Insights here

News-ID: 4213421 • Views:

More Releases from The Business Research Company

2025-2034 Superconducting Quantum Chip Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Superconducting Quantum Chip Market Outlook: Key Drivers, Emerging Cha …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Superconducting Quantum Chip Market Through 2025? The market size of superconducting quantum chips has shown a swift expansion in the past few years. It's forecasted to surge from a value of $0.74 billion in 2024, reaching $0.87 billion in 2025, with a
What Is Driving Global Responsible AI Governance Consulting Market Growth in 2025: The Role of Growing Adoption Of Generative AI Tools Due To Rising Regulatory Compliance And AI Transparency Needs
What Is Driving Global Responsible AI Governance Consulting Market Growth in 202 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Responsible AI Governance Consulting Market Size By 2025? The market size for responsible AI governance consulting has seen substantial growth recently. Projections show it will expand from $0.29 billion in 2024 to $0.43 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 49.0%.
Expansion Of Industrial Fleets Fueling The Growth Of The Market Due To Rising E-Commerce And Warehouse Automation: Transformative Forces Shaping the Material Handling Equipment Telematics Market Landscape in 2025
Expansion Of Industrial Fleets Fueling The Growth Of The Market Due To Rising E- …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Material Handling Equipment Telematics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the size of the telematics market for material handling equipment has experienced swift growth. The market is projected to increase from $5.42 billion in 2024 to $6.14 billion in 2025,
Higher Educational Professional Audio-Visual (Pro AV) Market Poised to Hit $5.68 Billion by 2029 with Accelerating Growth Trends
Higher Educational Professional Audio-Visual (Pro AV) Market Poised to Hit $5.68 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Higher Educational Professional Audio-Visual (Pro AV) Industry Market Size Be by 2025? The market size for professional audio-visual (pro av) in the higher education sector has seen robust growth in the past few years. The market is projected to increase from a value of $3.54 billion

All 5 Releases


More Releases for Neurocutaneous

Neurocutaneous Disorder Market Trends, Demand, and Future Outlook
Neurocutaneous Disorder market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Neurocutaneous Disorder Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as
Neurocutaneous Syndrome Market to Continue Impressive Measured Growth through 20 …
The Neurocutaneous Syndrome Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/neurocutaneous-syndrome-market What is the projected
Neurocutaneous Disorder Market Growth, Trends, Forecast and COVID-19 Impacts (20 …
Global Neurocutaneous Disorder Market Research Report: By Type (Tuberous Sclerosis (TS), Neurofibromatosis (NF), Sturge-Weber Syndrome, A-T, VHL), by Diagnosis (MRI, CT, EEG), End-User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast Till 2023 Neurocutaneous Disorder Market: Increasing cases of sclerosis are expected to benefit the global neurocutaneous disorder market at a strong CAGR of 6.5% GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/5937 Regional Analysis The global neurocutaneous disorder market consists of regions, namely, the
Global and Regional Neurocutaneous Disorder Market Analysis by Types, Applicatio …
Global Neurocutaneous Disorder Market Size, Status and Forecast 2019-2025; the latest report focuses on current market status, estimated forecast, growth opportunities, key market and top players. The objectives of this report is to present the Neurocutaneous Disorder development in United States, Europe, China, Japan, Southeast Asia, India, and Central & South America. This report helps to understand key player of the Neurocutaneous Disorder market and analyse their development plan and
Neurocutaneous Disorder Market in England will Double in Six Years New Data Show …
Market Highlights: The neurocutaneous syndrome is a group of neurologic disorders of brain, spine, and the peripheral nervous system. These diseases are lifelong conditions that may induce a tumor growth inside the skin, organs, skeletal bones, brain, and spinal cord. These disorders are usually genetic and arise due to abnormal cell development at the embryo stage. The result is characterized by the development of tumors in various parts of the body. Even
Neurocutaneous Disorder Market Research Report – Forecast to 2023
Neurocutaneous Disorder Market: Top Players • Valeant Pharmaceuticals International, Inc. (U.S.) • Allergan (U.S.) • Syneron Medical Ltd (U.S.) • Medtronic Plc (U.S.) • Cutera, Inc. (U.S.) • St Jude Medical, Inc. (U.S.) • Pfizer Inc. (U.S.) • Novartis AG (Switzerland) • Abbott Laboratories Inc. (U.S.) • UCB S.A. (Belgium) • Sanofi SA (France) • Shire Plc (Ireland) • F. Hoffmann-La Roche AG (Switzerland) • Aleva Neurotherapeutics SA (Switzerland) • Johnson & Johnson (U.S.) Market Scenario: The neurocutaneous syndrome is a group of neurologic disorders of brain, spine, and the peripheral nervous system. These diseases are lifelong conditions that may induce